In research published today in the journal Cerebral Cortex, a team of scientists led by the University of Cambridge and the Medical Research Council (MRC) Cognition and Brain Sciences Unit, Cambridge, studie ...
Drugs that target insulin pathways to slow or stop the growth of brain tumors are going in the right direction but appear to be on the wrong track, according to new research at Rice University.
A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to choosing strategies, specifically deciding to attack an opponent or defend one's position.
Researchers at the NFCR Center for Cancer System Informatics at MD Anderson Cancer Center have discovered a key factor that may explain drug resistance in glioblastoma (GBM), the most common and deadliest form of brain cancer.